Back to Journals » Breast Cancer: Targets and Therapy » Volume 15
Letter
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models [Letter]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
1,800 | Dovepress* | 1,748+ | 43 | 1,791 | |
PubMed Central* | 52 | 26 | 78 | ||
Totals | 1,800 | 69 | 1,869 | ||
*Since 19 December 2023 |
View citations on PubMed Central and Google Scholar